Vibrant Therapeutics
PrivateLast Round
Early Funding
Jan 12, 2026
Total Funding Raised
$64.35M
Momentum Score
50 /100
Company Overview
Vibrant Therapeutics is a biotechnology company that leverages a multidisciplinary approach, integrating antibody discovery, protein engineering, and computational tools to develop innovative biotherapeutics for patients with critical illnesses.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vibrant Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Vibrant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 12, 2026 | ||||
| Series A | Aug 25, 2025 | ||||
| Series A Extension | Aug 25, 2025 | ||||
| Series A | Jul 19, 2023 |
Vibrant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Principle Venture Limited | Early Funding |
| Advantage Capital | Series A |
| Northern Light Venture Capital | Early Funding |
| Bayland Capital | Early Funding |
| HongShan | Early Funding |
| Trinity Innovation Fund | Series A |
| Pfizer Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 292% MoM, from 275 to 1.1K.
- Jan 15, 2026
Han Lee appointed co-chief executive officer alongside founder Larry Wang.
Vibrant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vibrant Therapeutics's valuation, stock price, and market status.
